We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

40 hedge funds and large institutions have $9.73M invested in Acer Therapeutics Inc in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $8.34M → $9.73M (+$1.39M)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

0% more funds holding

Funds holding: 40 → 40 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
40
Holders Change
–
Holders Change %
0%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
14
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$209K
2
PPA
Parametric Portfolio Associates
Washington
+$122K
3
JP Morgan Chase
JP Morgan Chase
New York
+$57.8K
4
Deutsche Bank
Deutsche Bank
Germany
+$38.2K
5
UBS Group
UBS Group
Switzerland
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$320K
2
JGC
J. Goldman & Co
New York
-$269K
3
Goldman Sachs
Goldman Sachs
New York
-$174K
4
State Street
State Street
Massachusetts
-$132K
5
Millennium Management
Millennium Management
New York
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$27K +$867 +255 +4%
OSAM
27
O'Shaughnessy Asset Management
Connecticut
$14K +$12.2K +3,593 New
AIG
28
American International Group
New York
$13K -$92 -27 -0.9%
BCA
29
Berman Capital Advisors
Georgia
$11K – – –
MAM
30
Meeder Asset Management
Ohio
$6K -$18.9K -5,548 -78%
Citigroup
31
Citigroup
New York
$5K +$1.61K +473 +53%
TRCT
32
Tower Research Capital (TRC)
New York
$4K +$3.62K +1,065 New
Bank of America
33
Bank of America
North Carolina
$3K -$1.71K -503 -44%
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$2.81K +$1.54K +452 +182%
AIP
35
Ameritas Investment Partners
Nebraska
$2K – – –
Wells Fargo
36
Wells Fargo
California
$2K +$10 +3 +0.7%
Legal & General Group
37
Legal & General Group
United Kingdom
$1K +$646 +190 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$1K +$843 +248 +855%
Millennium Management
39
Millennium Management
New York
– -$48K -15,304 Closed
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
– -$36K -11,330 Closed
N
41
Nuveen
North Carolina
– -$33K -10,452 Closed
Victory Capital Management
42
Victory Capital Management
Texas
– -$3K -787 Closed
1
2

ACER Hedge Fund Activity: Q4 2019 in Review

40 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2019, worth a combined $9.73M — up 17% from $8.34M a quarter earlier.

Fund positioning in ACER was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 14 added to existing stakes and 13 trimmed.

The largest buyer was Federated Hermes, adding an estimated $209K. The largest seller was Stonepine Capital Management, cutting an estimated $320K.

  • 40 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $9.73M of Acer Therapeutics Inc stock for Q4 2019, up 17% quarter-over-quarter.
  • 4 funds opened new Acer Therapeutics Inc positions in Q4 2019 and 4 closed out, a net change of 0 holders.
  • The largest Acer Therapeutics Inc buyer in Q4 2019 was Federated Hermes, an estimated $209K added.
  • The largest Acer Therapeutics Inc seller in Q4 2019 was Stonepine Capital Management, an estimated $320K sold.

Based on aggregated 13F filings for Q4 2019.